Created with Sketch.
12 minutes | Jun 19, 2021
SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
31 minutes | Jun 17, 2021
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
31 minutes | Jun 14, 2021
A Discussion With Dr. John Quinlan; Readmission Risk for RCVS
The first segment features Dr. Stacey Clardy in conversation with 2021 Ted Burns Humanism in Neurology Award recipient Dr. John Quinlan. In the second part of the podcast, Dr. Andy Southerland discusses the risk of readmission following inpatient admission for reversible cerebral vasoconstriction syndrome with Dr. Santiago Ortega-Gutierrez.
26 minutes | Jun 7, 2021
Physical Therapy Referrals For Back Pain; The SELECT Trial for Large Vessel Occlusion
In the first segment, Dr. Jeff Ratliff discusses primary care management for acute sciatica and physical therapy referrals with Dr. Julie Fritz. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Amrou Sarraj about efficacy and safety of direct endovascular thrombectomy compared to bridging therapy in patients with large vessel occlusions.
59 minutes | Jun 1, 2021
Alzheimer's Disease Diagnostics & Treatments (Neurology Recall June 2021)
This month's replay of past episodes showcases a selection of interviews by Drs. Jeff Burns, Jason Crowell, and Gregg Day on updates in Alzheimer's disease diagnostics and the impact of future therapies, featuring Drs. Michael Weiner, Randall Bateman, Erik Musiek, Joseph Therriault, and Yvette Sheline.
21 minutes | May 31, 2021
Concussion Biomarkers in Saliva; Non-invasive Biomarkers of Intracranial Pressure
In the first segment, Dr. Alex Menze speaks with Prof. Antonio Belli about the role of salivary small non-coding RNAs in the diagnosis of sport-related concussion. In the second part of the podcast, Dr. David Lapides talks to Dr. Linda D’Antona about the utility of brain MRI and ophthalmic biomarkers for the prediction of intracranial hypertension.
27 minutes | May 24, 2021
Pregnancy and Stroke; Myasthenia Gravis and Pregnancy
In the first segment, Dr. Stacey Clardy speaks with Dr. Petra Ijäs about the incidence of stroke during pregnancy or puerperium in Finland from 1987-2016. In the second part of the podcast, Dr. David Lapides talks with Dr. Emma Ciafaloni about management of pregnancy in myasthenia gravis.
23 minutes | May 17, 2021
Natural History of PLS; Stratifying Risk in ICH
In the first segment, Dr. Jason Crowell discusses a natural history study of “pure” primary lateral sclerosis with Dr. Anhar Hassan. In the second part of the podcast, Dr. Andy Southerland talks with Dr. Roland Faigle about the assessment of critical care needs for patients with spontaneous intracerebral hemorrhage.
29 minutes | May 10, 2021
Developing a Brain Machine Interface; Association of Huntington CAG Repeats With Cognition
In the first segment, Dr. Andy Southerland talks with Dr. Mijail Serruya about developing a brain-machine interface for patients with stroke. In the second part of the podcast, Dr. Jason Crowell discusses the relationship between CAG repeat length and cognition in adult patients with Dr. Jordan Schultz.
23 minutes | May 3, 2021
Diagnostic Criteria for Traumatic Encephalopathy Syndrome; Trends in Neurology Drug Payments
In the first segment, Dr. Alex Menze talks to Dr. Robert Stern about developing NINDS consensus diagnostic criteria for traumatic encephalopathy syndrome. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Adam de Havenon about five-year cost trends and utilization of neurologist-prescribed drugs for Medicare Part D beneficiaries.
35 minutes | May 1, 2021
History of the Neurologic Exam (Neurology Recall May 2021)
This month's replay of past episodes features a selection of Neurology Minute segments in which Dr. Chris Boes discusses the history of neurology and the neurologic exam.
21 minutes | Apr 26, 2021
Long Term Effects of Cholinesterase Inhibitors; Pharmacovigilance in MS
In the first segment, Dr. Jeff Burns speaks with Prof. Maria Eriksdotter about whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk. In the second part of the podcast, Dr. David Lapides talks with Dr. Martijn Wijburg about pharmacovigilance of patients treated with disease-modifying therapies for MS.
14 minutes | Apr 22, 2021
SPECIAL REPORT: Update on the Johnson & Johnson COVID-19 Vaccine and Blood Clot Risk
Dr. Derek Stitt speaks with FDA Center for Biologics Evaluation and Research Director Dr. Peter Marks about cases of thrombosis after the Johnson & Johnson COVID-19 vaccine, potential risk factors, and suggestions for patient care.
31 minutes | Apr 19, 2021
Chronic Immune Sensory Polyradiculopathy; Ethical Issues in Neurology Research
In the first segment, Dr. Ted Burns talks with Drs. P. James B. Dyck and Shahar Shelly about clinical, neurophysiological, and pathological features of CISP-plus in comparison to CISP. In the second part of the podcast, Dr. David Lapides discusses important ethical issues encountered in neurological clinical research with Dr. Benjamin Tolchin.
25 minutes | Apr 12, 2021
Pregnancy and NMO; COVID-19 Health Disparities
In the first segment, Dr. David Lapides talks with Dr. Nicolas Collongues about pregnancy in patients with neuromyelitis optica spectrum disorder. In the second part of the podcast, Dr. Jason Crowell discusses racial and ethnic health disparities exacerbated by COVID-19 with Drs. Leo Lopez III and Louis Hart.
28 minutes | Apr 5, 2021
Financial COIs in Neurology Journals; Direct to Consumer Alzheimer's Testing
In the first segment, Dr. Stacey Clardy talks to Jade Smith about financial conflicts of interest of authors published in high-impact neurology journals. In the second part of the podcast, Dr. Jason Crowell speaks with Dr. Emily Largent about potential advancements and ethical challenges associated with blood testing for Alzheimer disease.
53 minutes | Apr 1, 2021
Updates in Epilepsy (Neurology Recall April 2021)
This month's replay of past episodes features four segments in which Dr. Fábio Nascimento discusses the diagnosis and management of epilepsy with Drs. Elizabeth Thiele, Helen Cross, Orrin Devinsky, and Atul Maheshwari. For discussion questions for your next journal club talk, go here.
33 minutes | Mar 29, 2021
Seizure Frequency and Treatment During Pregnancy; Genetic Testing in Epileptic Encephalopathy
In the first segment, Dr. Halley Alexander speaks with Dr. Page Pennell about seizure frequency and treatment during pregnancy. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Elizabeth Emma Palmer about genetic testing in epileptic encephalopathy. Access resources for clinicians and families with information on when to consider genetic testing for epilepsy, what tests are available, and what their advantages or limitations may be.
29 minutes | Mar 22, 2021
Portrait Of A Parent With Alzheimer's; Bimagrumab in Inclusion Body Myositis
In the first segment, Dr. David Lapides speaks with Prof. Yvonne Latty about her personal experience of having a parent with Alzheimer disease. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Amato about bimagrumab in sporadic inclusion body myositis.
29 minutes | Mar 15, 2021
Occipital Neuralgia; Are we ready for gene testing in Parkinson’s?
In the first segment, Dr. Teshamae Monteith talks with Dr. Paul Mathew on the prevalence of occipital neuralgia at a community hospital-based headache clinic. In the second part of the podcast, Dr. Jeffrey Ratliff talks with Drs. Lola Cook and Roy Alcalay about genetic testing for Parkinson disease.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021